SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey
Authors:
Open Access
- 23 November 2021
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 17, 100317
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Gesundheit
- World Health Organization
- Mongolian National University of Medical Sciences
This publication has 11 references indexed in Scilit:
- kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care WorkersEuropean Journal of Internal Medicine, 2021
- Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based studyThe Lancet Global Health, 2021
- SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional studyThe Lancet Infectious Diseases, 2021
- Viral and serological testing of SARS-CoV-2 among health care workers and patients in VietnamThe Lancet Regional Health - Western Pacific, 2021
- Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in ItalyTumori Journal, 2020
- Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patientsThe Lancet Regional Health - Western Pacific, 2020
- Early policy actions and emergency response to the COVID-19 pandemic in Mongolia: experiences and challengesThe Lancet Global Health, 2020
- Estimation of the unvaccinated among those aged less than 25 years according to aimag and its association with incidence of measles outbreak 2015-2016 in Mongolia2020
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessmentNature Communications, 2020
- Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort studyThe Lancet Microbe, 2020